HADAŠOVÁ, Eva, Veronika MINAŘÍKOVÁ, Miroslav DOSTÁLEK, Lucia ZAHRADNÍKOVÁ and Jan JUŘICA. Methamphetamine-induced changes in the activities of drug-metabolizing enzymes: "in vivo - in vitro" correlation studies. In Monitoring Molecules in Neuroscience. první. Cagliari, Itálie: University of Cagliari, 2006, p. 415-417.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Methamphetamine-induced changes in the activities of drug-metabolizing enzymes: "in vivo - in vitro" correlation studies
Name in Czech Změny v aktivitě metabolizujících enzymů vyvolané metamfetaminem: korelační studie "in vivo" . in vitro"
Authors HADAŠOVÁ, Eva, Veronika MINAŘÍKOVÁ, Miroslav DOSTÁLEK, Lucia ZAHRADNÍKOVÁ and Jan JUŘICA.
Edition první. Cagliari, Itálie, Monitoring Molecules in Neuroscience, p. 415-417, 3 pp. 2006.
Publisher University of Cagliari
Other information
Original language English
Type of outcome Proceedings paper
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Keywords in English methamphetamine; drug metabolism; pharmacokinetics; liver perfusion; rat;
Tags drug metabolism, liver perfusion, methamphetamine, pharmacokinetics, rat
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Eva McCaskey Hadašová, CSc., učo 709. Changed: 12/12/2006 18:20.
Abstract
The aim of the present study was to ascertain the influence of MET on activities of rat isoforms of CYP enzymes, mainly of CYP2C, CYP2D and CYP3A. In order to comprise the complexity of the possible pharmacokinetic changes evoked by methamphetamine, several series of experiments on various models and levels were performed in Wistar rats treated with MET: 1) the pharmacokinetic study in vivo; 2) the study on the isolated perfused rat liver; 3) the study on the rat liver microsomes. The results obtained in the isolated perfused rat liver confirmed the stimulatory effect of MET treatment on the CYP2D enzyme subfamily as it was observed in the in vivo experiments; AUC of dextromethorphan was significantly decreased (p<0.001) but Cl of dextromethorphan was significantly increased. Concurrently, the AUC of the O-demethylated metabolite dextrorphan was markedly increased (p<0.001). Furthermore, there was demonstrated a highly significant stimulation of CYP2C6 (p<0.001) in the isolated perfused liver when tolbutamid was used as a selective substrate. On the other hand, the experiments in the isolated liver did not confirm the stimulatory effect of MET on CYP3A subfamily as it could be suggested on the base of the in vivo pharmacokinetic experiments. the study performed in the liver microsomes supplied the detailed view about the direct effects of the in vivo pretreatment of rats with MET on the specific microsomal enzymes. Out of the monooxygenases tested, i.e. ethylresorufin-O-deethylase (EROD, CYP1A1/2), pentylresorufin-O-deethylase (PROD, CYP2B), ethoxycoumarin-O-deethylase (ECOD, CYP2A), erythromycine-N-demethylase (ERDM, CYP3A), 4-nitrophenol hydroxylase (NPH, CYP2E1) and dextromethorphan-O-demethylase (DXDM, CYP2D6), only CYP2D showed an insignificant stimulation and CYP2E1 was markedly inhibited.
Abstract (in Czech)
Cílem studie bylo objasnit vliv metamfetaminu na aktivitu potkaních izoforem CYP enzymů.
Links
MSM0021622404, plan (intention)Name: Vnitřní organizace a neurobiologické mechanismy funkčních systémů CNS
Investor: Ministry of Education, Youth and Sports of the CR, The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.
PrintDisplayed: 22/5/2024 02:00